All patients | Cooling method | Crude analysis | Multivariable analysis | Propensity score analysis | P value | ||
---|---|---|---|---|---|---|---|
SC | EC | OR (95% CI) | AOR (95% CI)a | OR (95% CI)b | |||
SC vs. EC as endovascular device and excluding dialysis cooling | |||||||
Overall | 378/1060 (35.7) | 330/946 (34.9) | 48/114 (42.1) | 1.36 (0.91–2.02) | 2.17 (1.31–3.60) | 1.75 (1.18–2.59) | 0.005 |
Shockable | 304/504 (60.3) | 270/452 (59.7) | 34/52 (65.4) | 1.27 (0.70–2.32) | 1.89 (0.87–4.10) | 1.75 (0.93–3.29) | 0.081 |
Non-shockable | 74/556 (13.3) | 60/494 (12.1) | 14/62 (22.6) | 2.11 (1.10–4.06) | 2.91 (1.43–5.91) | 2.31 (1.20–4.43) | 0.012 |
SC vs. EC after excluding patients treated with both SC and EC method | |||||||
Overall | 369/1055 (35.0) | 322/931 (34.6) | 47/124 (37.9) | 1.15 (0.78–1.70) | 1.56 (0.87–2.80) | 1.30 (0.88–1.91) | 0.184 |
Shockable | 296/495 (59.8) | 264/441 (59.9) | 32/54 (59.3) | 0.98 (0.55–1.73) | 1.45 (0.63–3.33) | 1.34 (0.75–2.42) | 0.325 |
Non-shockable | 73/560 (13.0) | 58/490 (11.8) | 15/70 (21.4) | 2.03 (1.08–3.83) | 2.25 (1.18–4.32) | 2.19 (1.17–4.12) | 0.014 |